Replies

https://twitter.com/ColumbiaSurgery/status/1245476381938630656

“… There is new information today on the continuing evolution of our testing policy. Our machine capacity for PCR viral antigen assays is very large but remains resource-constrained (swabs, reagents). Nonetheless, the PCR test is being expanded to include all patents who are being admitted, regardless of symptoms or exposure history. This applies to all patients having urgent or emergent operations, which has obvious relevance to our Department. NYP is eager to include testing for all health care workers, but today our capacity is still too limited for that step. That population will likely be addressed with a combination of PCR testing for antigen and serum testing for antibody. Antibody testing keeps coming tomorrow, rather than today, but I’m confident we’ll get there. I have the impression that media descriptions of testing availability are woefully disconnected from actual capabilities on the ground, at least here in the epicenter, which makes it difficult to establish realistic expectations...”